Company profile: Accentia Biopharmaceuticals
1.1 - Company Overview
Company description
- Provider of immunotherapies for autoimmune-related diseases and cancer; services include hospice care providing emotional support and professional medical help to terminally ill patients, and hypnosis therapy to help patients and families deal with emotional stress, improve communication, and build stronger relationships.
Products and services
- Immunotherapies: Discovers, develops, and commercializes R&D-focused immunotherapies targeting autoimmune-related diseases and cancer, advancing therapies from discovery through development to market
- Hospice Care: Delivers clinical-grade emotional support and professional medical help for terminally ill patients, ensuring last wishes are fulfilled and assisting with managing personal affairs during final days
- Hypnosis Therapy: Supplies therapeutic-grade hypnosis to help patients and families manage emotional stress, improve communication, and build stronger relationships
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Accentia Biopharmaceuticals
Sigyn Therapeutics
HQ: United States
Website
- Description: Provider of therapeutic technologies for inflammatory diseases, including Sigyn Therapy, a blood purification technology extracting pathogens and inflammatory mediators for endotoxemia, sepsis, and drug-resistant infections; ChemoPrep to enhance chemotherapy delivery by depleting tumor-derived extracellular vesicles; ChemoPure to reduce toxicity by removing off-target agents; and ImmunePrep to boost antibody-based immunotherapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sigyn Therapeutics company profile →
VG Life Sciences
HQ: United States
Website
- Description: Provider of drug therapy discovery and development for cancers, infectious diseases, inflammatory diseases, and autoimmune disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VG Life Sciences company profile →
Sparrow Pharmaceuticals
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapies for disorders of corticosteroid excess, including SPI-62, an oral HSD-1 inhibitor designed to reduce intracellular cortisol in conditions like endogenous Cushing’s syndrome and autonomous cortisol secretion, and SPI-47, combining SPI-62 with prednisolone for autoimmune diseases such as polymyalgia rheumatica.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sparrow Pharmaceuticals company profile →
Amira Pharmaceuticals
HQ: United States
Website
- Description: Provider of small-molecule pharmaceutical research focused on the discovery and early development of new drugs to treat inflammatory disease, leveraging unparalleled insights into bioactive lipid pathways and complex signaling processes controlling conditions including asthma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amira Pharmaceuticals company profile →
Endpoint Health
HQ: United States
Website
- Description: Provider of precision immunology solutions, including targeted therapeutics tailored to patient biology for immune-mediated diseases, companion diagnostics to personalize treatment, a precision immunology ecosystem with pharma, biotech, diagnostics providers and clinical data registries, and clinical collaborations with over 60 global health systems to develop precision therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endpoint Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Accentia Biopharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Accentia Biopharmaceuticals
2.2 - Growth funds investing in similar companies to Accentia Biopharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Accentia Biopharmaceuticals
4.2 - Public trading comparable groups for Accentia Biopharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →